Thu. Nov 28th, 2024

GIOSTAR Announces FDA Clearance of the IND for Starting PHASE-2 Clinical Trial for Developing Specific Stem Cell Therapy for Type II Diabetes. – Business Wire

Byadmin

Nov 14, 2024

By admin

Related Post

Taking charge of diabetes – VA.gov Home | Veterans Affairs

Nov 28, 2024 admin

Tirzepatide cuts diabetes risk by 90% in obese patients, study shows – News-Medical.Net

Nov 28, 2024 admin

Younger Age at Diabetes Diagnosis Tied to Higher Risk for Later Dementia – Physician's Weekly

Nov 28, 2024 admin

Leave a Reply Cancel reply

You missed

Taking charge of diabetes – VA.gov Home | Veterans Affairs

Nov 28, 2024 admin

Tirzepatide cuts diabetes risk by 90% in obese patients, study shows – News-Medical.Net

Nov 28, 2024 admin

Younger Age at Diabetes Diagnosis Tied to Higher Risk for Later Dementia – Physician's Weekly

Nov 28, 2024 admin

Empowering Diabetes Care: The Evolving Role of Pharmacists – Pharmacy Times

Nov 28, 2024 admin